Comprehensive haematological indices reference intervals for a healthy Omani population: First comprehensive study in Gulf Cooperation Council (GCC) and Middle Eastern countries based on age, gender and ABO blood group comparison

Adhra Al-Mawali; Avinash Daniel Pinto; Raiya Al-Busaidi; Rabab H. Al-Lawati; Magdi Morsi

doi:10.1371/journal.pone.0194497

Abstract

Background

Reference intervals for venous blood parameters differs with age, gender, geographic region, and ethnic groups. Hence local laboratory reference intervals are important to improve the diagnostic accuracy of health assessments and diseases. However, there have been no comprehensive published reference intervals established in Oman, the Gulf Cooperation Council or Middle Eastern countries. Hence, the aim of this study was to establish reference intervals for full blood count in healthy Omani adults.

Methods

Venous blood specimens were collected from 2202 healthy individuals aged 18 to 69 years from January 2012 to April 2017, and analysed by Sysmex XS-1000i and Cell-Dyn Sapphire automated haematology analysers. Results were statistically analysed and compared by gender, age, and ABO blood group. The lower and upper reference limits of the haematology reference intervals were established at the 2.5th and 97.5th percentiles respectively.

Results

Reference intervals were calculated for 17 haematology parameters which included red blood cell, white blood cell, and platelet parameters. Red blood cell (RBC), haemoglobin (HGB), haematocrit (HCT), platelet and platelet haematocrit counts of the healthy donors were significantly different between males and females at all ages (p < 0.05), with males having higher mean values of RBC, HGB and HCT than females. Other complete blood count parameters showed no significant differences between genders, age groups, instruments, or blood groups. Our study showed a lower haemoglobin limit for the normal reference interval in males and females than the currently used in Oman.

Conclusions

Data from this study established specific reference intervals which could be considered for general use in Oman. The differences in haematology reference intervals highlights the necessity to establish reference intervals for venous blood parameters among the healthy population in each country or at least in each region.

Citation: Al-Mawali A, Pinto AD, Al-Busaidi R, Al-Lawati RH, Morsi M (2018) Comprehensive haematological indices reference intervals for a healthy Omani population: First comprehensive study in Gulf Cooperation Council (GCC) and Middle Eastern countries based on age, gender and ABO blood group comparison. PLoS ONE 13(4): e0194497. https://doi.org/10.1371/journal.pone.0194497

Editor: Rainer Haeckel, Zentralkrankenhaus Bremen Mitte, GERMANY

Received: April 11, 2017; Accepted: February 21, 2018; Published: April 5, 2018

Copyright: © 2018 Al-Mawali et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper.

Funding: This work was supported by The Research Council Oman (47) to Adhra Al-Mawali (https://www.trc.gov.om/trcweb/). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

It is hard to underestimate the importance of clinical laboratory test results. Nearly 80% of physicians' medical decisions are based on information provided by laboratory reports [1]. Test results by themselves are of little value unless it is reported with the appropriate information for its interpretation. Typically, this information is provided in the form of a reference interval [2, 3].

Full blood count (FBC), also known as complete blood count (CBC), testing is the most frequently performed haematology test in any clinical setting. Analysis of FBC by haematology analysers is an essential and basic tool in the evaluation of many immunological, haematological and pathological disorders. Establishment of a normal reference interval is fundamental for precise clarification of disease diagnosis based on age, gender, ethnicity, genetic differences, and environmental factors [4].

FBC techniques have developed considerably in the last two decades and automated methods have now replaced manual methods. Automated haematology analysers utilise technological advancements to determine complete blood count more accurately. In addition, various novel blood cell parameters have been developed alongside to aid in diagnosis and management of several blood disorders [5–8].

Demographic, environmental, geographical area, and ethnic population are factors that may contribute to variations in these ranges around the world [9–11]. Dietary habits and occupational exposures are also factors that has been shown to affect reference interval [12–14]. Country-specific reference intervals for FBC of adult peripheral blood have been established in many countries around the world; however, there have been no specific comprehensive studies in Oman or the Gulf Cooperation Council (GCC) and Middle East, which investigated reference interval based on age, gender-specific, and ABO blood group. Due to the variability observed as a result of the factors, there is a great necessity for each country to establish its own reference intervals.

In Oman, there is no single study has been done to identify the reference interval for FBC. To the best of our knowledge, this is the first study in Oman and GCC that investigated reference interval; and the data was correlated with age, gender, and blood group, and two haematology analysers. This study identified reference interval for all FBC parameters, which can now be used as a reference when evaluating patient samples in Oman.

Materials and methods

Subjects and sample collection

The Central Blood Bank (CBB) is the primary blood bank for Ministry of Health in the Muscat region as well as referred samples from all over Oman. As per standard blood donation procedure, a blood donation form has to be filled prior to determining eligibility. Selection criteria for blood donation are based on a questionnaire which is given to each volunteer donor to assess their medical, demographic, and lifestyle information in addition to a physical examination by a clinician to determine fitness to donate blood. The exclusion criteria for blood donation is as below:

Age below 18 years;
Any type of illness, such as cancer, acute or chronic infection, diabetes, allergy or asthma requiring long-term treatment, epilepsy, cardiac or respiratory disease;
Surgery in the past 12 months prior to donation;
Blood donation within the past 3 months;
Body weight under 50kg;
Hypertension;
Any bleeding condition/blood disorder requiring medical attention
Vaccination taken in the past 4 weeks;
Diarrhoea in the past 2 weeks;
Pregnancy, or abortion/delivery within the past 12 months
Tattoos, ear or skin piercings, acupuncture, or traditional ‘wasam’ (local cautery) treatment/hijama (cupping therapy) in the past 12 months;
HIV/AIDS, Hepatitis, Syphilis, or a sexually transmitted disease;
Travel to malaria endemic areas, or development of febrile illness upon return

Informed consent which is taken as part of the blood donation process also covers the haematological parameters tested in this study. Ethical approval for the study was obtained from the Research and Ethical Review and Approval Committee, Ministry of Health. During blood donation, peripheral blood specimens were also collected in 2ml K3EDTA vacuette tubes by venepuncture for the reference interval study. A convenient sample of 2202 eligible apparently healthy normal Omani adult blood donors from CBB were taken for this study during the period of January 2012 to April 2017. Of the 2202 volunteer healthy eligible blood donors, 1879 were males and 323 were females. The blood donors were between 18 and 69 years of age (median 30 years). The blood specimens were collected in the morning (8am-12pm) and processed in the laboratory within 5 hours of blood collection.

Measuring instruments and parameters

The collected blood samples were analysed at the Royal Hospital (largest tertiary hospital) in the Sultanate of Oman. FBC parameters were measured using Sysmex XS-1000i (Sysmex Corp., Kobe, Japan) and Cell-Dyn Sapphire (Abbott Laboratories, Diagnostic Division, Abbott Park, IL, USA) haematology analysers. Currently, 95% of laboratories in Oman apply these two analysers in their routine practice. 17 haematology parameters were evaluated in this study which comprised red blood cell parameters of red blood cells count (RBC), haemoglobin (HGB), haematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), red cell distribution width (RDW); white blood cell parameters of white blood cells count (WBC), absolute neutrophil count (NEUT), absolute lymphocyte count (LYMPH), absolute monocyte count (MONO), absolute eosinophil count (EOS) and absolute basophil count (BASO); and platelet parameters of thrombocyte/platelet count (PLT), platelet distribution width (PDW), mean platelet volume (MPV), and platelet crit (PCT). Both instruments were evaluated and a correlation between instruments was performed.

Quality control & Quality assurance

Quality controls (3 different levels of low, medium and high) for the respective instruments provided by Abbott, USA and Sysmex, Japan were run daily as part of the internal quality control thrice a day. Calibration of instruments as well as quality control monitoring between instruments was carried out regularly as part of scheduled maintenance to ensure precision and reliability of results. The laboratory is covered by UKAS Medical Laboratory accreditation (ISO 15189).

Statistical analysis

Data were analysed using the IBM Statistical Package for Social Sciences (SPSS Version 20.0). Outliers were excluded by Horn’s algorithm using Tukey’s interquartile fences identifies multiple outliers located at the upper and lower extremities [15]. The criterion for rejection is values exceeding interquartile (IQ) fences set at Q₁-1.5*IQR and Q₃+1.5*IQR (where IQR = interquartile range; IQR = Q₃-Q₁ where Q₁ AND Q₃ are the 25^th and 75^th percentiles, respectively. This is more stringent than Dixon’s range statistic, which favours retention. The two instruments (Sysmex and Cell-Dyn) and the two genders were compared using the Kolmogorov-Smirnov Z-test and the Median test whilst comparisons in age groups were done using ANOVA and Kruskal-Wallis H test. For multiple comparisons of groups that showed differences in variances analysis, Tukey’s test was used. Non-parametric methods were used to establish the FBC values between the 2.5^th and 97.5^th percentiles that included 95% of the reference sample group data (Fig 1).

Download:

Fig 1. Statistical methodology employed in estimating reference intervals.

Lower and upper reference limits were determined using the 2.5th and 97.5th percentiles.

https://doi.org/10.1371/journal.pone.0194497.g001

Results

Instrument-related findings

Statistically significant differences were seen only in PLT and LYMPH using the two instruments. However, the differences between the mean values were minor and not clinically significant, and thus the data from both instruments were pooled together to calculate the reference intervals for the total population (Fig 2).

Download:

Fig 2. Comparison of mean red blood cell count (RBC), white blood cell count (WBC), haemoglobin (HGB), and lymphocyte (LYM) values between different instruments.

Instrument 1 denotes Cell-Dyn Sapphire and Instrument 2 denotes Sysmex XS-100i.

https://doi.org/10.1371/journal.pone.0194497.g002

Gender-related findings

Significant differences were found between males and females (P < 0.05) for RBC, HGB, HCT, PLT parameters (Fig 3). The rest of the parameters showed no statistical differences between males and females and thus the data was pooled together whilst preparing the reference intervals.

Download:

Fig 3. Variations of mean red blood cell count (RBC), white blood cell count (WBC), haemoglobin (HGB), and lymphocyte (LYM) values according to age and gender.

* denotes significantly higher values (P < 0.05) between genders in the same age group.

https://doi.org/10.1371/journal.pone.0194497.g003

Age-related findings

The findings were divided into 4 age groups: 18–29, 30–39, 40–49, and 50+. Very minor differences with no statistical significance were seen among the different age groups and hence the data between age groups were pooled in together (Fig 3).

Blood group-related findings

There were no statistical differences found in the subjects between the four blood groups of A, B, AB & O and their respective Rh factors (Fig 4).

Download:

Fig 4. Comparison of mean red blood cell count (RBC), white blood cell count (WBC), haemoglobin (HGB), and lymphocyte (LYM) values amongst ABO blood group.

The selected analytes show no significant difference amongst ABO blood group.

https://doi.org/10.1371/journal.pone.0194497.g004

Estimating blood reference intervals

The reference intervals did not differ by gender, except for RBC, HGB, HCT, and PLT. Lower and upper reference limits were determined using the 2.5^th and 97.5^th percentiles, shown in Table 1. The qualified rate of validation which is the percentage of donors falling in the established reference interval was not less than 95% for all parameters (based on CLSI guideline for verification of reference intervals) [16].

Download:

Table 1. Estimated reference intervals of different FBC parameters.

https://doi.org/10.1371/journal.pone.0194497.t001

Discussion

The FBC is the most commonly requested diagnostic haematology laboratory test. A reference interval set up for FBC aids clinicians in diagnosis and evaluation by distinguishing between a normal and a pathological situation. Technological advances in automation contribute to the need to set up and consequently periodically evaluate reference intervals in order to ensure the requirements of quality and precision. Different laboratories are urged to define reference intervals for the local population as well as providing national recommendations based on the established reference intervals because FBC values are impacted by various factors, which include age, gender, altitude, ethnic background [17]. Thus it is important that each country or region establish their own reference interval for FBC parameters.

To the best of our knowledge, this is the first study that reports comprehensive reference intervals for the full range of diagnostic haematology parameters in Oman, GCC and the Middle East. This study investigated the influences of instrument type, age, gender, and blood group on the FBC reference intervals in healthy donors of the Omani population as they presented to the Central Blood Bank.

In our study, RBC reference intervals reported are similar to the reported reference intervals by American, Malaysian, and French studies [18–20]. The upper RBC limit for both males and females was higher in Oman (Table 2) which was similar to an African study [21]. This study is also in line with the general knowledge about the significant difference in haemoglobin levels between males and females as a result of the effects of androgen and oestrogen on erythropoiesis [22]. The HGB values are lower than the recommended reference intervals by World Health Organization (WHO) for non-anaemic persons with the severity in Oman being assessed as ‘Severe’ [23, 24]. The World Health Survey in Oman, a community-based household survey, reported the prevalence of anaemia to be 28% in the Omani population taking into consideration the WHO haemoglobin lower limits of 13g/dL and 12g/dL for males and females respectively [25], with prevalence of anaemia among non-pregnant women (aged 15–49) at 35% as of 2011 [26]. However, this study shows this is actually a normal reference interval for the Omani population. Interestingly, a similar finding was also seen in Kuwait, another Middle Eastern country [27]. Our lower HGB limit for females are similar to Malaysian & Chinese populations, whilst the lower HGB limit for males are similar to an African study [28]. Lower haemoglobin levels in our cohort may be attributed to the existence of genetic blood disorders [29, 30]. As predicted by the haemoglobin differences between males and females, a significant difference is similarly found in the haematocrit values between genders in our study which is similar to other published data [18, 19] due to higher androgen levels in males and chronic menstrual blood loss in females [31].

Download:

Table 2. Comparison of estimated reference intervals of different FBC parameters between various populations.

https://doi.org/10.1371/journal.pone.0194497.t002

Both the upper and lower limits of MCV values are lower than those found in America, Malaysia,China, and Kuwait [17, 18, 27, 31]. Only an African study had its lower MCV limit similar to that found in our study [28]. A possible explanation to the low MCV values seen in our population is the high prevalence of thalassemia’s in the Omani population [32]. It is critical to segregate the population into two groups to establish a more accurate reference interval in the future as molecular analysis is not done in this study. The Clinical and Laboratory Standards Institute (CLSI) guidelines are unclear on how to proceed in the event of apparently healthy individuals having asymptomatic conditions impacting on reference intervals [16]. However, the reported MCHC values in our population is in line with other populations [18, 31]. Although donors are generally considered to be healthy people, they may suffer from iron depletion and subclinical iron deficiency which may have effects on certain red blood cell parameters.

PLT values showed significant differences between males and females in our population. The differences in platelet values between genders has been seen in other studies but the causes of the variation are unclear [33]. Our platelet values were similar to that found in the American and Malaysian studies [18, 19]. However, there is a noticeable difference when compared to African and Chinese studies which had a lower PLT limit [28, 31].

With respect to leukocytes, our population has much lower WBC and NEUT limits when compared to other populations, though the lower NEUT limit is similar to that reported in an African study population [28]. Our NEUT reference interval results is similar to the ranges previously reported by an Omani study on 126 donors [34]. Interestingly, ‘benign’ neutropenia is prevalent among Arabs [35, 36] and is possibly caused as a result of a genetic adaptation with its molecular mechanism still unknown [37]. This evidence and variations among different ethnic groups thus supports the necessity of establishing a local reference interval for Omani’s, so as to avoid any adverse consequences of wrong classification or misdiagnosis as neutropenia. However, the rest of the leukocyte parameters are in line with other international studies.

Limitations

One of the limitations of this study is that blood donors are not the ideal population for healthy individuals but they are representative of ‘apparently’ healthy people. In addition, the number of women in the study were far less than men because the donors were volunteer blood donors coming for blood donation and there are more stringent criteria for women to donate according to the local guideline followed adapted from the WHO Blood Donor Selection Guideline [38]. Furthermore, even though a convenient sample has been taken, it is unlikely to have caused a selection bias due to the large sample size collected and the inclusion of consecutive eligible donors on the days of selection. CLSI guidelines recommend the establishment of reference intervals with at least 120 reference individuals using a non-parametric approach [16].

This study only included adults and not paediatric subjects due to eligibility criteria for donor blood collection. Another limitation is the number of 50+ individuals were considerably lower than the other age groups which may have had an impact on the reference intervals in this age category.

Conclusion

This study successfully created a set of reference intervals for the majority of haematology parameters studied in healthy adult Omani population based on age, gender, and ABO blood group using two instruments. These reference intervals have important clinical implications, especially in the management of immunological and haematological disorders. The authors stress that each laboratory must validate the transference of established reference intervals (according to CLSI guideline). The reference interval established by this study could be adopted as a reference for clinical practice decisions in Oman. A follow-up study will need to be done to validate our results with iron status tests.

Supporting information

S1 Ranges. Current reference intervals used in Oman.

https://doi.org/10.1371/journal.pone.0194497.s001

(PDF)

Acknowledgments

The authors would like to acknowledge and thank the staff of the Central Blood Bank, Oman involved in this study for their invaluable support.

References

1. Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results. American Journal of Clinical Pathology. 2010;133(2):180–6. pmid:20093226
- View Article
- PubMed/NCBI
- Google Scholar
2. Yadav D. Reference Interval for Clinical Laboratory Test Parameters. Biochemistry and Analytical Biochemistry. 2015;4(4):1.
- View Article
- Google Scholar
3. Al-Mawali A, Pinto AD, Al-Busaidi R, Al-Zakwani I. Lymphocyte subsets: Reference ranges in an age- and gender-balanced population of Omani healthy adults. Cytometry Part A. 2013;83(8):739–44.
- View Article
- Google Scholar
4. Ozarda Y. Reference intervals: current status, recent developments and future considerations. Biochemia medica. 2016;26(1):5–16. pmid:26981015
- View Article
- PubMed/NCBI
- Google Scholar
5. Pekelharing J, Hauss O, De Jonge R, Lokhoff J, Sodikromo J, Spaans M, et al. Haematology reference intervals for established and novel parameters in healthy adults. Sysmex Journal International. 2010;20(1):1–9.
- View Article
- Google Scholar
6. Al-Mawali A, Gillis D, Lewis I. Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones. Journal of hematology & oncology. 2016;9(1):61.
- View Article
- Google Scholar
7. Al-Mawali A. Leukemic stem cells shows the way for novel target of acute myeloid leukemia therapy. J Stem Cell Res Ther. 2013;3(4):151.
- View Article
- Google Scholar
8. Al-Mawali A, Gillis D, Lewis I. Characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplication in the FLT3 gene. Oman medical journal. 2013;28(6):432. pmid:24223248
- View Article
- PubMed/NCBI
- Google Scholar
9. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstetrics & Gynecology. 2009;114(6):1326–31.
- View Article
- Google Scholar
10. Biino G, Santimone I, Minelli C, Sorice R, Frongia B, Traglia M, et al. Age-and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects' data. PloS one. 2013;8(1):e54289. pmid:23382888
- View Article
- PubMed/NCBI
- Google Scholar
11. Saxena S, Wong ET. Heterogeneity of common hematologic parameters among racial, ethnic, and gender subgroups. Archives of pathology & laboratory medicine. 1990;114(7):715–9.
- View Article
- Google Scholar
12. Dasgupta A, Sepulveda JL. Accurate Results in the Clinical Laboratory: A Guide to Error Detection and Correction (Chapter 2: Effect of Age, Gender, Diet, Exercise, and Ethnicity on Laboratory Test Results): Newnes; 2013.
13. Gräsbeck R. Reference values, why and how. Scandinavian Journal of Clinical and Laboratory Investigation. 1990;50(sup201):45–53.
- View Article
- Google Scholar
14. Al-Mawali A. Non-Communicable Diseases: Shining a Light on Cardiovascular Disease, Oman’s Biggest Killer. Oman medical journal. 2015;30(4):227. pmid:26366254
- View Article
- PubMed/NCBI
- Google Scholar
15. Horn PS, Feng L, Li Y, Pesce AJ. Effect of outliers and nonhealthy individuals on reference interval estimation. Clinical Chemistry. 2001;47(12):2137–45. pmid:11719478
- View Article
- PubMed/NCBI
- Google Scholar
16. Horowitz GL, Altaie S, Boyd JC. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline: CLSI; 2010.
17. Cheng C, Chan J, Cembrowski GS, Van Assendelft O. Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race. Laboratory hematology: official publication of the International Society for Laboratory Hematology. 2003;10(1):42–53.
- View Article
- Google Scholar
18. Ambayya A, Su AT, Osman NH, Nik-Samsudin NR, Khalid K, Chang KM, et al. Haematological reference intervals in a multiethnic population. PloS one. 2014;9(3):e91968. Epub 2014/03/20. pmid:24642526; PubMed Central PMCID: PMC3958408.
- View Article
- PubMed/NCBI
- Google Scholar
19. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Normal reference laboratory values. New England Journal of Medicine. 2004;351(15):1548–63. pmid:15470219
- View Article
- PubMed/NCBI
- Google Scholar
20. Troussard X, Cornet E, Bardet V, Couaillac J-P, Fossat C, Luce J-C, et al. Full blood count normal reference values for adults in France. Journal of clinical pathology. 2013:jclinpath-2013-201687.
- View Article
- Google Scholar
21. Samaneka WP, Mandozana G, Tinago W, Nhando N, Mgodi NM, Bwakura-Dangarembizi MF, et al. Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population. PloS one. 2016;11(11):e0165821. pmid:27812172
- View Article
- PubMed/NCBI
- Google Scholar
22. Jelkmann W. Regulation of erythropoietin production. The Journal of physiology. 2011;589(6):1251–8.
- View Article
- Google Scholar
23. World Health Organization. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. 2008.
24. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System (WHO/NMH/NHD/MNM/11.1). 2011 [cited 2016 August 1]. Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdf
25. Al Riyami A, Elaty MA, Morsi M, Al Kharusi H, Al Shukaily W, Jaju S. Oman world health survey: part 1-methodology, sociodemographic profile and epidemiology of non-communicable diseases in oman. Oman Med J. 2012;27(5):425–43. pmid:23074559
- View Article
- PubMed/NCBI
- Google Scholar
26. Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. The Lancet Global Health. 2013;1(1):e16–e25. pmid:25103581
- View Article
- PubMed/NCBI
- Google Scholar
27. Al-Jafar H. Provisional Study of Kuwait Adult Hematology Reference Range. J Hematol Thromb. 2016;2(1):4.
- View Article
- Google Scholar
28. Karita E, Ketter N, Price MA, Kayitenkore K, Kaleebu P, Nanvubya A, et al. CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa. PloS one. 2009;4(2):e4401. pmid:19197365
- View Article
- PubMed/NCBI
- Google Scholar
29. Rajab A, Al Salmi Q, Jaffer J, Mohammed A, Patton M. Congenital and genetic disorders in the Sultanate of Oman. First attempt to assess healthcare needs. Journal of community genetics. 2014;5(3):283. pmid:24585275
- View Article
- PubMed/NCBI
- Google Scholar
30. Hassan SM, Harteveld CL, Bakker E, Giordano PC. Molecular Spectrum of α-Globin Gene Defects in the Omani Population. Hemoglobin. 2014;38(6):422–6. pmid:25370869
- View Article
- PubMed/NCBI
- Google Scholar
31. Wu X, Zhao M, Pan B, Zhang J, Peng M, Wang L, et al. Complete blood count reference intervals for healthy Han Chinese adults. PloS one. 2015;10(3):e0119669. Epub 2015/03/15. pmid:25769040; PubMed Central PMCID: PMC4358890.
- View Article
- PubMed/NCBI
- Google Scholar
32. Hassan SM, Hamza N, Jaffer Al-Lawatiya F, Jaffer Mohammed A, Harteveld CL, Rajab A, et al. Extended molecular spectrum of beta- and alpha-thalassemia in Oman. Hemoglobin. 2010;34(2):127–34. Epub 2010/04/01. pmid:20353347.
- View Article
- PubMed/NCBI
- Google Scholar
33. Segal JB, Moliterno AR. Platelet Counts Differ by Sex, Ethnicity, and Age in the United States. Annals of Epidemiology. 2006;16(2):123–30. pmid:16246584
- View Article
- PubMed/NCBI
- Google Scholar
34. Al-Ankoodi Y, Rawther S. Neutropenia. Saudi medical journal. 2004;25(10):1507–8. pmid:15494839
- View Article
- PubMed/NCBI
- Google Scholar
35. Denic S, Showqi S, Klein C, Takala M, Nagelkerke N, Agarwal MM. Prevalence, phenotype and inheritance of benign neutropenia in Arabs. BMC Hematology. 2009;9(1):3.
- View Article
- Google Scholar
36. Gari M, Dakhakhni M, Gari A, Alshihri E, Al-Jahdali R, Narasimhan K, et al., editors. Incidence and potential causative factors associated with chronic benign neutropenia in the Kingdom of Saudi Arabia. BMC proceedings; 2015: BioMed Central.
37. Kobayashi Y. Neutrophil biology: an update. EXCLI Journal. 2015;14:220–7. PMC4650944. pmid:26600743
- View Article
- PubMed/NCBI
- Google Scholar
38. Organization WH. Blood donor selection: guidelines on assessing donor suitability for blood donation: World Health Organization; 2012.

[ref1] 1. Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results. American Journal of Clinical Pathology. 2010;133(2):180–6. pmid:20093226
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Yadav D. Reference Interval for Clinical Laboratory Test Parameters. Biochemistry and Analytical Biochemistry. 2015;4(4):1.
View Article
Google Scholar

[6] View Article

[7] Google Scholar

[ref3] 3. Al-Mawali A, Pinto AD, Al-Busaidi R, Al-Zakwani I. Lymphocyte subsets: Reference ranges in an age- and gender-balanced population of Omani healthy adults. Cytometry Part A. 2013;83(8):739–44.
View Article
Google Scholar

[9] View Article

[10] Google Scholar

[ref4] 4. Ozarda Y. Reference intervals: current status, recent developments and future considerations. Biochemia medica. 2016;26(1):5–16. pmid:26981015
View Article
PubMed/NCBI
Google Scholar

[12] View Article

[13] PubMed/NCBI

[14] Google Scholar

[ref5] 5. Pekelharing J, Hauss O, De Jonge R, Lokhoff J, Sodikromo J, Spaans M, et al. Haematology reference intervals for established and novel parameters in healthy adults. Sysmex Journal International. 2010;20(1):1–9.
View Article
Google Scholar

[16] View Article

[17] Google Scholar

[ref6] 6. Al-Mawali A, Gillis D, Lewis I. Immunoprofiling of leukemic stem cells CD34+/CD38−/CD123+ delineate FLT3/ITD-positive clones. Journal of hematology & oncology. 2016;9(1):61.
View Article
Google Scholar

[19] View Article

[20] Google Scholar

[ref7] 7. Al-Mawali A. Leukemic stem cells shows the way for novel target of acute myeloid leukemia therapy. J Stem Cell Res Ther. 2013;3(4):151.
View Article
Google Scholar

[22] View Article

[23] Google Scholar

[ref8] 8. Al-Mawali A, Gillis D, Lewis I. Characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplication in the FLT3 gene. Oman medical journal. 2013;28(6):432. pmid:24223248
View Article
PubMed/NCBI
Google Scholar

[25] View Article

[26] PubMed/NCBI

[27] Google Scholar

[ref9] 9. Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstetrics & Gynecology. 2009;114(6):1326–31.
View Article
Google Scholar

[29] View Article

[30] Google Scholar

[ref10] 10. Biino G, Santimone I, Minelli C, Sorice R, Frongia B, Traglia M, et al. Age-and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects' data. PloS one. 2013;8(1):e54289. pmid:23382888
View Article
PubMed/NCBI
Google Scholar

[32] View Article

[33] PubMed/NCBI

[34] Google Scholar

[ref11] 11. Saxena S, Wong ET. Heterogeneity of common hematologic parameters among racial, ethnic, and gender subgroups. Archives of pathology & laboratory medicine. 1990;114(7):715–9.
View Article
Google Scholar

[36] View Article

[37] Google Scholar

[ref12] 12. Dasgupta A, Sepulveda JL. Accurate Results in the Clinical Laboratory: A Guide to Error Detection and Correction (Chapter 2: Effect of Age, Gender, Diet, Exercise, and Ethnicity on Laboratory Test Results): Newnes; 2013.

[ref13] 13. Gräsbeck R. Reference values, why and how. Scandinavian Journal of Clinical and Laboratory Investigation. 1990;50(sup201):45–53.
View Article
Google Scholar

[40] View Article

[41] Google Scholar

[ref14] 14. Al-Mawali A. Non-Communicable Diseases: Shining a Light on Cardiovascular Disease, Oman’s Biggest Killer. Oman medical journal. 2015;30(4):227. pmid:26366254
View Article
PubMed/NCBI
Google Scholar

[43] View Article

[44] PubMed/NCBI

[45] Google Scholar

[ref15] 15. Horn PS, Feng L, Li Y, Pesce AJ. Effect of outliers and nonhealthy individuals on reference interval estimation. Clinical Chemistry. 2001;47(12):2137–45. pmid:11719478
View Article
PubMed/NCBI
Google Scholar

[47] View Article

[48] PubMed/NCBI

[49] Google Scholar

[ref16] 16. Horowitz GL, Altaie S, Boyd JC. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline: CLSI; 2010.

[ref17] 17. Cheng C, Chan J, Cembrowski GS, Van Assendelft O. Complete blood count reference interval diagrams derived from NHANES III: stratification by age, sex, and race. Laboratory hematology: official publication of the International Society for Laboratory Hematology. 2003;10(1):42–53.
View Article
Google Scholar

[52] View Article

[53] Google Scholar

[ref18] 18. Ambayya A, Su AT, Osman NH, Nik-Samsudin NR, Khalid K, Chang KM, et al. Haematological reference intervals in a multiethnic population. PloS one. 2014;9(3):e91968. Epub 2014/03/20. pmid:24642526; PubMed Central PMCID: PMC3958408.
View Article
PubMed/NCBI
Google Scholar

[55] View Article

[56] PubMed/NCBI

[57] Google Scholar

[ref19] 19. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Normal reference laboratory values. New England Journal of Medicine. 2004;351(15):1548–63. pmid:15470219
View Article
PubMed/NCBI
Google Scholar

[59] View Article

[60] PubMed/NCBI

[61] Google Scholar

[ref20] 20. Troussard X, Cornet E, Bardet V, Couaillac J-P, Fossat C, Luce J-C, et al. Full blood count normal reference values for adults in France. Journal of clinical pathology. 2013:jclinpath-2013-201687.
View Article
Google Scholar

[63] View Article

[64] Google Scholar

[ref21] 21. Samaneka WP, Mandozana G, Tinago W, Nhando N, Mgodi NM, Bwakura-Dangarembizi MF, et al. Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population. PloS one. 2016;11(11):e0165821. pmid:27812172
View Article
PubMed/NCBI
Google Scholar

[66] View Article

[67] PubMed/NCBI

[68] Google Scholar

[ref22] 22. Jelkmann W. Regulation of erythropoietin production. The Journal of physiology. 2011;589(6):1251–8.
View Article
Google Scholar

[70] View Article

[71] Google Scholar

[ref23] 23. World Health Organization. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. 2008.

[ref24] 24. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System (WHO/NMH/NHD/MNM/11.1). 2011 [cited 2016 August 1]. Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdf

[ref25] 25. Al Riyami A, Elaty MA, Morsi M, Al Kharusi H, Al Shukaily W, Jaju S. Oman world health survey: part 1-methodology, sociodemographic profile and epidemiology of non-communicable diseases in oman. Oman Med J. 2012;27(5):425–43. pmid:23074559
View Article
PubMed/NCBI
Google Scholar

[75] View Article

[76] PubMed/NCBI

[77] Google Scholar

[ref26] 26. Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. The Lancet Global Health. 2013;1(1):e16–e25. pmid:25103581
View Article
PubMed/NCBI
Google Scholar

[79] View Article

[80] PubMed/NCBI

[81] Google Scholar

[ref27] 27. Al-Jafar H. Provisional Study of Kuwait Adult Hematology Reference Range. J Hematol Thromb. 2016;2(1):4.
View Article
Google Scholar

[83] View Article

[84] Google Scholar

[ref28] 28. Karita E, Ketter N, Price MA, Kayitenkore K, Kaleebu P, Nanvubya A, et al. CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa. PloS one. 2009;4(2):e4401. pmid:19197365
View Article
PubMed/NCBI
Google Scholar

[86] View Article

[87] PubMed/NCBI

[88] Google Scholar

[ref29] 29. Rajab A, Al Salmi Q, Jaffer J, Mohammed A, Patton M. Congenital and genetic disorders in the Sultanate of Oman. First attempt to assess healthcare needs. Journal of community genetics. 2014;5(3):283. pmid:24585275
View Article
PubMed/NCBI
Google Scholar

[90] View Article

[91] PubMed/NCBI

[92] Google Scholar

[ref30] 30. Hassan SM, Harteveld CL, Bakker E, Giordano PC. Molecular Spectrum of α-Globin Gene Defects in the Omani Population. Hemoglobin. 2014;38(6):422–6. pmid:25370869
View Article
PubMed/NCBI
Google Scholar

[94] View Article

[95] PubMed/NCBI

[96] Google Scholar

[ref31] 31. Wu X, Zhao M, Pan B, Zhang J, Peng M, Wang L, et al. Complete blood count reference intervals for healthy Han Chinese adults. PloS one. 2015;10(3):e0119669. Epub 2015/03/15. pmid:25769040; PubMed Central PMCID: PMC4358890.
View Article
PubMed/NCBI
Google Scholar

[98] View Article

[99] PubMed/NCBI

[100] Google Scholar

[ref32] 32. Hassan SM, Hamza N, Jaffer Al-Lawatiya F, Jaffer Mohammed A, Harteveld CL, Rajab A, et al. Extended molecular spectrum of beta- and alpha-thalassemia in Oman. Hemoglobin. 2010;34(2):127–34. Epub 2010/04/01. pmid:20353347.
View Article
PubMed/NCBI
Google Scholar

[102] View Article

[103] PubMed/NCBI

[104] Google Scholar

[ref33] 33. Segal JB, Moliterno AR. Platelet Counts Differ by Sex, Ethnicity, and Age in the United States. Annals of Epidemiology. 2006;16(2):123–30. pmid:16246584
View Article
PubMed/NCBI
Google Scholar

[106] View Article

[107] PubMed/NCBI

[108] Google Scholar

[ref34] 34. Al-Ankoodi Y, Rawther S. Neutropenia. Saudi medical journal. 2004;25(10):1507–8. pmid:15494839
View Article
PubMed/NCBI
Google Scholar

[110] View Article

[111] PubMed/NCBI

[112] Google Scholar

[ref35] 35. Denic S, Showqi S, Klein C, Takala M, Nagelkerke N, Agarwal MM. Prevalence, phenotype and inheritance of benign neutropenia in Arabs. BMC Hematology. 2009;9(1):3.
View Article
Google Scholar

[114] View Article

[115] Google Scholar

[ref36] 36. Gari M, Dakhakhni M, Gari A, Alshihri E, Al-Jahdali R, Narasimhan K, et al., editors. Incidence and potential causative factors associated with chronic benign neutropenia in the Kingdom of Saudi Arabia. BMC proceedings; 2015: BioMed Central.

[ref37] 37. Kobayashi Y. Neutrophil biology: an update. EXCLI Journal. 2015;14:220–7. PMC4650944. pmid:26600743
View Article
PubMed/NCBI
Google Scholar

[118] View Article

[119] PubMed/NCBI

[120] Google Scholar

[ref38] 38. Organization WH. Blood donor selection: guidelines on assessing donor suitability for blood donation: World Health Organization; 2012.

Figures

Abstract

Background

Methods

Results

Conclusions

Introduction

Materials and methods

Subjects and sample collection

Measuring instruments and parameters

Quality control & Quality assurance

Statistical analysis

Results

Instrument-related findings

Gender-related findings

Age-related findings

Blood group-related findings

Estimating blood reference intervals

Discussion

Limitations

Conclusion

Supporting information

S1 Ranges. Current reference intervals used in Oman.

Acknowledgments

References